InsidersTradesSigma
Follow the 梅花生物 stock price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Chemicals sector, 梅花生物 has recorded 9 insider filings. Market capitalisation: €22bn. The latest transaction was disclosed on 30 April 2026 (Purchase). Among the most active insiders: 常利斌. All data is accessible without an account.
9
Insider Decl.
n/a
Thresholds
€23m
8 ops.
Buy Volume
€68,647
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,487 of 28,832 companies
75.2
score / 100
Value88
Quality62
FCF yld8.7%
Earn yld15%
EV/EBITDA5.0x
ROE14%
Gross mgn19%
Net mgn14%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 April 2026
Declarations9 total
9 of 9 declarations
About 梅花生物
梅花生物 is a company specializing in chemistry and materials, listed on the XSHG market. It focuses on the research and development of innovative chemical products.